Eli Lilly and Company has completed its merger with AtaiBeckley Inc. as of September 11, 2026. This merger was finalized under the Agreement and Plan of Merger dated July 15, 2026. AtaiBeckley will now operate as a wholly owned subsidiary of Eli Lilly.
Company Information
Company
Eli Lilly and Company
Location
Indianapolis, Indiana, United States
About
Lilly is a medicine company turning science into healing to make life better for people around the world. They have been pioneering life-changing discoveries for nearly 150 years, and today their medicines help more than 51 million people across the globe. Lilly is focused on redefining diabetes care, treating obesity, advancing the fight against Alzheimer's disease, providing solutions to immune system disorders, and transforming difficult-to-treat cancers into manageable diseases. To learn more, visit Lilly.com and Lilly.com/news, or follow them on Facebook, Instagram and LinkedIn.
Don't miss Eli Lilly and Company's next move
Get an email the moment Eli Lilly and Company makes an acquisition, hires an exec, or expands, usually minutes after it happens.
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed
Frequently asked
Who acquired AtaiBeckley?
AtaiBeckley was acquired by Eli Lilly and Company, based in Indianapolis. The deal was reported on September 11, 2026. Lilly is a medicine company turning science into healing to make life better for people around the world. Eli Lilly and Company is publicly traded (LLY) and operates in Manufacturing.
When did Eli Lilly and Company acquire AtaiBeckley?
Eli Lilly and Company's acquisition of AtaiBeckley was reported on September 11, 2026. Eli Lilly and Company has completed its merger with AtaiBeckley Inc. as of September 11, 2026. This merger was finalized under the Agreement and Plan of Merger dated July 15, 2026. AtaiBeckley will now operate as a wholly owned subsidiary of Eli Lilly. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does AtaiBeckley do?
AtaiBeckley Inc. is a biotechnology company based in Delaware, primarily focused on the development of novel therapeutics for mental health disorders. It is publicly traded (ATAI), operating in Biotechnology, and is based in United States.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.